Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Cross-presenting CD103+ dendritic cells are protected from influenza virus infection
Julie Helft, … , Adolfo García-Sastre, Miriam Merad
Julie Helft, … , Adolfo García-Sastre, Miriam Merad
Published October 8, 2012
Citation Information: J Clin Invest. 2012;122(11):4037-4047. https://doi.org/10.1172/JCI60659.
View: Text | PDF
Research Article

Cross-presenting CD103+ dendritic cells are protected from influenza virus infection

  • Text
  • PDF
Abstract

CD8+ cytotoxic T cells are critical for viral clearance from the lungs upon influenza virus infection. The contribution of antigen cross-presentation by DCs to the induction of anti-viral cytotoxic T cells remains controversial. Here, we used a recombinant influenza virus expressing a nonstructural 1–GFP (NS1-GFP) reporter gene to visualize the route of antigen presentation by lung DCs upon viral infection in mice. We found that lung CD103+ DCs were the only subset of cells that carried intact GFP protein to the draining LNs. Strikingly, lung migratory CD103+ DCs were not productively infected by influenza virus and thus were able to induce virus-specific CD8+ T cells through the cross-presentation of antigens from virally infected cells. We also observed that CD103+ DC resistance to infection correlates with an increased anti-viral state in these cells that is dependent on the expression of type I IFN receptor. These results show that efficient cross-priming by migratory lung DCs is coupled to the acquisition of an anti-viral status, which is dependent on the type I IFN signaling pathway.

Authors

Julie Helft, Balaji Manicassamy, Pierre Guermonprez, Daigo Hashimoto, Aymeric Silvin, Judith Agudo, Brian D. Brown, Mirco Schmolke, Jennifer C. Miller, Marylene Leboeuf, Kenneth M. Murphy, Adolfo García-Sastre, Miriam Merad

×

Figure 2

Lung tissue migratory CD103+ DCs control anti-viral CD8+ T cell immunity.

Options: View larger image (or click on image) Download as PowerPoint
Lung tissue migratory CD103+ DCs control anti-viral CD8+ T cell immunity...
(A) WT and Ccr7–/– mice were infected with 107 PFUs of PR8-OTI virus. Forty-eight hours later, MLN cells were cocultured with CFSE-labeled CD8+ OT-I T cells for 3 days. Proliferation was measured by flow cytometry assessment of CFSE dilution (representative histograms). Graph represents the number of divided T cells per well. Each dot represents 1 mouse. (B) WT mice were infected with 107 PFUs of PR8-OTI virus. Lung migratory CD103+ DCs and CD11b+ DCs and LN-resident CD8+ and CD4+ DCs purified from the MLN 24 hours after infection were cocultured with CFSE-labeled CD8+ OT-I T cells for 3 days. Proliferation was measured by flow cytometry assessment of CFSE dilution (representative histograms). Graph represents the number of divided T cells per well after coculture with different numbers of DCs per well (DC:T ratio). Data are representative of 3 separate experiments. (C) CD45+CD11c+MHCII+ lung phagocyte populations (CD103+ DCs, CD11b+ DCs, and CD103–CD11b– alveolar macrophages) were analyzed by flow cytometry in naive WT and Batf3–/– mice. Representative percentages of each population in the CD45+CD11c+MHCII+ gate are noted. (D and E) WT and Batf3–/– mice were infected with 3 × 103 PFUs of NS1-GFP virus. Seven days later, the percentages and absolute numbers of NP-specific endogenous CD8+ T cells in the MLNs (D) and the lungs (E) were measured by flow cytometry using H2Db/ASNENMETM-specific dextramer staining. Graphs represent the percentage (%) and the absolute numbers (abs no.) of dextramer-positive CD8+ T cells among total CD3+CD8+B220– T cells. Data are representative of 3 separate experiments.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts